NDAINJECTIONINJECTABLE
Approved
Nov 1948
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 8m ago · AI intelligence enriched 8m ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xylocaine is a local anesthetic combination product containing lidocaine hydrochloride and epinephrine bitartrate, administered by injection. It is used to provide local or regional anesthesia for minor surgical procedures, dental work, and pain management. The lidocaine blocks nerve conduction while epinephrine causes vasoconstriction to prolong anesthetic effect and reduce systemic absorption.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating potential team restructuring and shift toward defensive strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
Started Feb 2011
27 enrolled
Morton's Neuroma
Career Relevance
Working on Xylocaine offers limited career growth as the product approaches loss of exclusivity with no active clinical development pipeline. Roles focus on defensive market management, pricing protection, and transition planning rather than innovation or expansion.
Brand Manager
Worked on XYLOCAINE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.